# Clinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection

> **NCT06135922** · PHASE1 · RECRUITING · sponsor: **Chinese PLA General Hospital** · enrollment: 9 (estimated)

## Conditions studied

- EBV-associated Hemophagocytic Lymphohistiocytosis
- EBV Infection

## Interventions

- **BIOLOGICAL:** EBV-TCR-T cells

## Key facts

- **NCT ID:** NCT06135922
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06135922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06135922, "Clinical Study of EBV-TCR-T Cells for EBV-associated Hemophagocytic Lymphohistiocytosis or EBV Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06135922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*